ENDEFR
Home › China › 深圳市海普洛斯生物科技有限公司

深圳市海普洛斯生物科技有限公司

企业 · 深圳市, China · LEI 300300RMRQ9RH6PYUG49
LEI lapsedgroup parent

Summary

深圳市海普洛斯生物科技有限公司 is registered in China and entered in the “National Enterprise Credit Information Publicity System” under number 9144030031174500XP. Its legal form is 企业 – enterprise (China). 深圳市海普洛斯生物科技有限公司 is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 7 May 2020 and the record was last updated on 1 Mar 2022. It has lapsed: renewal was due by 7 May 2022. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 7 May 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.

Company details

Legal form企业
enterprise (China)
RegisterNational Enterprise Credit Information Publicity System · Register website
Registration number9144030031174500XP
Registration authorityState Administration for Market Regulation
JurisdictionChina
Registered address深圳市前海深港合作区前湾一路1号A栋201室(入驻深圳市前海商务秘书有限公司)经营地址:深圳市南山区西丽街道松坪山路3号奥特迅电力大厦8楼, 510000 深圳市, China
Categorycompany or other legal entity
Statusactive
LEI300300RMRQ9RH6PYUG49
LEI statuslapsed
LEI first issued7 May 2020
LEI record last updated1 Mar 2022
Next LEI renewal7 May 2022
Corroboration of the LEI recordfully corroborated

Group membership

深圳市海普洛斯生物科技有限公司 this entity
江西海普洛斯医学检验实验室有限公司 China lapsed

Parent not reported to GLEIF

  • Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
  • Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.

Direct subsidiaries (1)